我们在嵌合抗原受体 T 细胞治疗 (CAR T) 方面处于领先地位。您也可以。这种新兴免疫疗法对患者自身的 CD4+ 和 CD8+ T 细胞进行重新编码，以识别和攻击癌症。现在，我们正在通过一些临床试验探索更多的可能性。随着公司规模的不断扩大，我们正在寻找注重质量、充满激情的员工来帮助公司进一步深入发展。现在，展现您对创新的热爱和对在这个激动人心的领域产生影响的渴望吧！
New State-of-the-Art Facility
Construction is underway for a new cell therapy manufacturing facility in Devens, MA. This is a part of Bristol Myers Squibb’s significant investment to support clinical and commercial manufacturing of transformative cell therapies for patients with aggressive hematological cancers. The Devens site will be equipped to enable quick ramp up of capacity for clinical and commercial cell therapy products. Manufacturing cell therapies is both operationally and technically complex because they are manufactured uniquely for each individual patient, and it is critical for companies to develop a reliable, quality supply and rapid turnaround time.
View Cellular Therapy Jobs in Devens
BMS is Planting a Flag in Europe with Leiden Manufacturing Facility
BMS has expanded into The Netherlands with a state-of-the-art CAR T Cell Therapy manufacturing facility at Leiden
BioScience Park to continue making advancements. With
innovative technologies and cutting-edge production
equipment, the new site will empower our team to research
and develop potentially life-saving treatments for patients
with many types of cancer.
Explore Our Roles in Leiden
Join Our Talent Community
We’re inspired every day by our incredibly interesting and
meaningful work—but there’s so much more to be uncovered
and explored. Your knowledge, skills and curiosity could be
helping us unlock the potential.
成为游戏规则改变者。将您的创新思维带给 BMS CAR T 团队，并帮助改善癌症患者的生活。
听一听 Jaymes 关于我们的 CAR T 团队及他们对癌症患者的承诺的看法。
Hear what Andreia has to say about our CAR T team and their impact on the lives of cancer patients.